Skip to main content
. 2020 Nov 22;143(12):3850–3864. doi: 10.1093/brain/awaa313

Table 1.

Demographic, clinical and neuropsychological participants' data

Controls Patients with svPPA P-value (η2)
Demographic and clinical data
Age, years 63.26 (6.8) 67.89 (6.7) <0.05 (0.109)
Education level, years 12.15 (3.1) 13.69 (4.3) 0.22 (0.044)
MoCA (/30) 27.60 (1.4) 19.87 (4.2) <0.0005 (0.598)
Disease duration, months NA 66.4 (47.8) NA
Background neuropsychological data
Semantic knowledge score 143.80 (0.4) 122.60 (31.5) <0.01 (0.176)
Lexical fluency (words) 24.35 (5.5) 14.33 (7.2) <0.0005 (0.378)
Category fluency (words) 34.85 (6.9) 14.80 (9.5) <0.0005 (0.558)
Forward verbal span 5.10 (0.8) 4.88 (1.2) 0.81 (0.002)
Backward verbal span 4.75 (0.9) 4.93 (0.9) 0.12 (0.074)
Letter and digit sequence span 10.50 (0.9) 8 (2.8) <0.05 (0.129)
Stroop interference, s 52.20 (24.6) 104.4 (99.7) 0.12 (0.075)
TMT B − A, s 53.60 (30.0) 84.47 (43.9) 0.09 (0.085)
Brixton Spatial Anticipation Task (errors) 10.35 (3.9) 17.93 (4.1) <0.0005 (0.415)
Rey complex figure (/36) 35.50 (0.8) 34.94 (1.5) 0.26 (0.038)
Rey complex figure, recall (/36) 21.50 (6.6) 13.38 (6.9) <0.005 (0.286)
TOM-15 (/15) 14.05 (1.4) 12.87 (1.8) 0.06 (0.110)

Mean (standard deviation) demographic, clinical and neuropsychological scores, and differences (P-values and η2 as effect size) between groups. MoCA = Montreal Cognitive Assessment; TMT = Trail Making Test; TOM-15 = Theory of Mind-15; NA = not available.